These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 1008344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transit time analysis of the forced expiratory vital capacity in cystic fibrosis.
    Neuburger N, Levison H, Kruger K.
    Am Rev Respir Dis; 1976 Oct; 114(4):753-9. PubMed ID: 970749
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
    Wang EE, Prober CG, Manson B, Corey M, Levison H.
    N Engl J Med; 1984 Dec 27; 311(26):1653-8. PubMed ID: 6504106
    [Abstract] [Full Text] [Related]

  • 7. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec 27; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.
    Zemel BS, Kawchak DA, Cnaan A, Zhao H, Scanlin TF, Stallings VA.
    Pediatr Res; 1996 Oct 27; 40(4):578-86. PubMed ID: 8888286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lung function from infancy to preschool in a cohort of children with cystic fibrosis.
    Brumback LC, Davis SD, Kerby GS, Kloster M, Johnson R, Castile R, Hiatt PW, Hart M, Rosenfeld M.
    Eur Respir J; 2013 Jan 27; 41(1):60-6. PubMed ID: 22653767
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction.
    Thomson MA, Quirk P, Swanson CE, Thomas BJ, Holt TL, Francis PJ, Shepherd RW.
    Nutrition; 1995 Jan 27; 11(4):350-4. PubMed ID: 8580575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP, Shih SC, Chuang CK, Lee KS, Chen MR, Niu DM, Chiu PC, Lin SJ, Lin HY.
    Pediatr Pulmonol; 2014 Mar 27; 49(3):277-84. PubMed ID: 23401495
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
    Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G.
    Am Rev Respir Dis; 1980 Dec 27; 122(6):859-66. PubMed ID: 7458059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.